Industry News - Page 2 - Medical Marketing and Media

RSS | Login | Register

Genentech acquires Xolair partner Tanox

November 10, 2006

Genentech has agreed to acquire its Xolair co-marketer, the Houston-based biotech firm Tanox, in a deal worth $919 million.

3M sheds pharma unit for $2.1 billion

November 09, 2006

3M has agreed to sell-off its global pharmaceuticals business, which makes dermatology, women’s health, cardiology and respiratory treatments, for $2.1 billion.

Abbott to buy Kos for $3.7 billion

November 07, 2006

Abbott has agreed to buy specialty firm Kos for $3.7 billion, a move that complements its cardiovascular franchise and boosts its pipeline.

Schering-Plough CEO calls takeover prices 'breath-taking'

November 07, 2006

The prices being paid in the recent rash of pharmaceutical acquisition deals are “breath-taking,” Schering-Plough CEO Fred Hassan said in an interview with Marketwatch.com.

Lilly, BMS part of California investigation of anti-psychotics

November 07, 2006

The California attorney general’s office expanded its probe into the marketing of anti-psychotic drugs, serving subpoenas to Eli Lilly and Bristol-Myers Squibb, the companies have said.

Trial results cloud future of Pfizer's torcetrapib

November 07, 2006

Pfizer confirmed that its leading pipeline candidate torcetrapib raised blood pressure in clinical trial patients more than previously reported.

Lilly, BMS part of California investigation of anti-psychotics

November 06, 2006

The California attorney general’s office expanded its probe into the marketing of anti-psychotic drugs, serving subpoenas to Eli Lilly and Bristol-Myers Squibb, the companies have said.

HealthMedia acquires MySelfHelp.com

November 01, 2006

Behavioral change-focused relationship marketing firm HealthMedia announced today that it has acquired the consumer Web site MySelfHelp.com.

NIH scientists seeking new work in wake of tougher disclosure rules

October 30, 2006

Nearly 40% of scientists researching diseases and cures at the National Institutes of Health (NIH) are considering new jobs to escape strict ethics rules, a recent survey said.